Fresenius Medical Care AG & Co. KGaA (FMS) 20-F2021 FY Annual report (foreign)

Filed: 22 Feb 22, 1:17pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absorption, alienate, Alpha, anesthesia, antibody, anticoagulation, ANVISA, appetite, ARUG, awaiting, BBB, binomial, Biology, Bluetooth, BMW, Brazilian, Brigham, BS, built, catheterization, cell, cessation, Chinese, climate, cloud, column, conservative, Cox, CRRT, curative, database, decode, DeepHealth, Deerfield, desist, difelikefalin, Dodge, ECMO, editing, effectually, EHR, embodying, ESG, ESKD, Evanston, exemplified, expiry, explanation, feedback, fit, footnote, forefront, forfeiture, Francisco, freight, Frenova, FTE, Gdansk, gene, genome, genomic, Gesetz, gregory, guiding, halt, hardship, HemoflowTM, hydrolayer, hygiene, IBOR, IC, ID, IGBCE, Imaging, immune, Inline, insider, interbank, interval, Ireland, islet, JSC, judged, Kawasumi, KDE, Kellogg, kit, Lending, lifted, lightweight, logic, Lundberg, MBA, MBBP, MDSAP, MedTech, Memo, Minnesota, MUFG, multicurrency, multifiltratepro, MyTraining, Nephew, nonrecurring, Northwestern, Organisation, overarching, overcome, overspend, PAYGO, permeability, Pillar, pivotal, plausibility, preclinical, proliferation, PureFlowSL, QR, reality, reallocation, regime, reinforce, reopened, repeat, repository, Rescue, resistance, resume, sample, sampling, San, schematic, shadow, simulation, Smith, socioeconomic, sorensen, Spring, stratifying, surprise, surveillance, Swingline, telehealth, temporal, theHub, thing, timeframe, trainer, turnover, umbrella, Umsetzung, unanticipated, unavoidable, undiscounted, undrawn, unvaccinated, upheld, upholding, usable, vendor, VersiPD, viral, VR, Warsaw, weighing, workplace, Xenotransplant, zur, zweiten

Removed: AIC, AIMD, AKI, AMP, Amsterdam, annum, appendix, Arizona, averaged, bachelor, Ben, Berlin, binominal, Biotronik, Blue, Bosch, BPCI, cardiogenic, Carolina, Charit, Chase, clean, client, closest, collaborating, combinational, Commerzbank, concrete, consequentially, contact, contradictory, converting, costly, debit, delivered, Den, disbursed, dismantle, disregard, Distinction, distributer, Duesseldorf, EPS, Ergo, existed, exploring, Fargo, feature, Gallian, greatly, Hemoflow, Hong, hospitalist, hyperinflation, idea, IFRIC, implantable, Indiana, instruction, intensive, intensivist, intervention, Jersey, JPMorgan, Kentucky, Kong, Kuerbitz, laid, leasehold, lie, Lufthansa, Lutz, meaningful, mechanical, Mississippi, Nashville, NDA, NHSN, observed, optimal, oriented, originating, personam, Physiotherapy, prohibiting, proportionally, purified, Reciprocally, reclassification, recommenced, refinanced, repealed, retail, revaluation, Roche, Ronald, room, Rx, SASU, Schilling, securitization, selectively, semiannually, sentence, shock, shortening, sleep, soluble, specification, standardize, Stiefenhofer, Stiftung, Summit, Suntrust, supplying, swing, syndication, Tennessee, UFJ, undervalued, Unicredit, VA, ventilation, venue, visit, VU, web

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated FMS transcripts

FMS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 13.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 20-F of Fresenius Medical Care AG & Co. KGaA (the “Company”) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Rice Powell, Chief Executive Officer and Chairman of the Management Board of Fresenius Medical Care Management AG, the general partner of the Company, and Helen Giza, Chief Financial Officer and Member of the Management Board of Fresenius Medical Care Management AG, the general partner of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



	By:	/s/ Rice Powell
	Chief Executive Officer and
	Chairman of the Management Board of
	Fresenius Medical Care Management AG,
	General Partner of
	Fresenius Medical Care AG & Co. KGaA

	February 22, 2022

	By:	/s/ Helen Giza
	Chief Financial Officer and
	Member of the Management Board of Fresenius Medical Care Management AG,
	General Partner of
	Fresenius Medical Care AG & Co. KGaA

	February 22, 2022

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.